Anti-Hyperalgesic Efficacy of Acetyl L-Carnitine (ALCAR) Against Visceral Pain Induced by Colitis: Involvement of Glia in the Enteric and Central Nervous System
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914841 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Elena Lucarini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Pharmacology and Toxicology Section, University of Florence, 501…. Hauptthemen laut MEDLINE: Visceral Pain, Colitis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Florence, Ministry of Education, Universities and Research, Alfasigma S.p.A.
Abstract (Originalsprache)
The management of abdominal pain in patients affected by inflammatory bowel diseases (IBDs) still represents a problem because of the lack of effective treatments. Acetyl L-carnitine (ALCAR) has proved useful in the treatment of different types of chronic pain with excellent tolerability. The present work aimed at evaluating the anti-hyperalgesic efficacy of ALCAR in a model of persistent visceral pain associated with colitis induced by 2,4-dinitrobenzene sulfonic acid (DNBS) injection. Two different protocols were applied. In the preventive protocol, ALCAR was administered daily starting 14 days to 24 h before the delivery of DNBS. In the interventive protocol, ALCAR was daily administered starting the same day of DNBS injection, and the treatment was continued for 14 days. In both cases, ALCAR significantly reduced the establishment of visceral hyperalgesia in DNBS-treated animals, though the interventive protocol showed a greater efficacy than the preventive one. The interventive protocol partially reduced colon damage in rats, counteracting enteric glia and spinal astrocyte activation resulting from colitis, as analyzed by immunofluorescence. On the other hand, the preventive protocol effectively protected enteric neurons from the inflammatory insult. These findings suggest the putative usefulness of ALCAR as a food supplement for patients suffering from IBDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Pharmacology and Toxicology Section, University of Florence, 50139 Florence, Italy.
ORCID-Profile: Elena Lucarini, Laura Micheli, Alessandra Toti, Francesco Margiotta, Lorenzo Di Cesare Mannelli
Förderung
- University of Florence
- Ministry of Education, Universities and Research
- Alfasigma S.p.A
- Italian Ministry of Education, University and Research (MIUR)
Zitieren
APA
Lucarini, E., Micheli, L., Toti, A., Ciampi, C., Margiotta, F., Di Cesare Mannelli, L., & Ghelardini, C. (2023). Anti-Hyperalgesic Efficacy of Acetyl L-Carnitine (ALCAR) Against Visceral Pain Induced by Colitis: Involvement of Glia in the Enteric and Central Nervous System. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914841
Vancouver
Lucarini E, Micheli L, Toti A, Ciampi C, Margiotta F, Di Cesare Mannelli L, et al. Anti-Hyperalgesic Efficacy of Acetyl L-Carnitine (ALCAR) Against Visceral Pain Induced by Colitis: Involvement of Glia in the Enteric and Central Nervous System. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914841
BibTeX
@article{Lucarini2023,
author = {Lucarini, Elena and Micheli, Laura and Toti, Alessandra and Ciampi, Clara and Margiotta, Francesco and Di Cesare Mannelli, Lorenzo and Ghelardini, Carla},
title = {Anti-Hyperalgesic Efficacy of Acetyl L-Carnitine (ALCAR) Against Visceral Pain Induced by Colitis: Involvement of Glia in the Enteric and Central Nervous System},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914841}
}
EUVIMED